Search Grant Opportunities

Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)

ID: RFA-AI-21-009 • Type: Posted
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Who is eligible to apply for this grant?
I'd like to anonymously submit a question to the procurement officer(s)
Loading

Description

To encourage multidisciplinary teams to characterize mechanisms that impact resistance to HIV broadly neutralizing antibodies (bNAbs) and develop strategies to prevent and overcome HIV resistance to bNAbs.

Overview

Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
On 3/30/21 the National Institutes of Health posted grant opportunity RFA-AI-21-009 for Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) with funding of $2.5 million. The grant will be issued under grant program 93.855 Allergy and Infectious Diseases Research.

Timing

Posted Date
March 30, 2021, 12:00 a.m. EDT
Closing Date
July 30, 2021, 12:00 a.m. EDT Past Due
Last Updated
March 30, 2021, 12:05 p.m. EDT
Version
1
Archive Date
Sept. 4, 2021

Eligibility

Eligible Applicants
Native American tribal organizations (other than Federally recognized tribal governments)
Independent school districts
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
County governments
Public housing authorities/Indian housing authorities
Public and State controlled institutions of higher education
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
State governments
Additional Info
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$2,500,000
Estimated Number of Grants
Not Listed

Contacts

Contact
National Institutes of Health
Contact Email
Email Description
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Contact Phone
(301) 402-2541

Documents

Posted documents for RFA-AI-21-009

Grant Awards

Grants awarded through RFA-AI-21-009

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to RFA-AI-21-009

Experts for Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)

Recommended subject matter experts available for hire